Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 130
Filter
1.
Curr Pharm Biotechnol ; 22(5): 706-717, 2021.
Article in English | MEDLINE | ID: mdl-33208066

ABSTRACT

BACKGROUND: Cardiovascular Diseases (CVDs) such as stroke, high blood pressure, peripheral vascular disease, ischemic heart disease and acute myocardial infarction are some of the leading causes of death. To treat CVDs, commercially available thrombolytic agents are widely used. However, these thrombolytic agents have various side effects. Alternatively, fibrinolytic enzymes from bacterial sources are highly safe and have direct blood clot lytic activity. METHODS: A fibrinolytic enzyme producing bacterial strain, Bacillus flexus BF12, was isolated from a solar saltpan in Kanyakumari District, Tamilnadu, India. Enzyme production was improved by optimizing physical factors and nutritional factors. RESULTS: A novel fibrinolytic enzyme was isolated from a strain of the studied B. flexus BF12. Enzyme production was enhanced significantly by optimizing process parameters. The critical physical factors (pH and salinity) and influencing nutritional factors (carbon, nitrogen and ions) were optimized by one variable at a time approach, followed by the statistical method. The strain BF12 was highly active at alkaline pH (>7.0) and between 4 and 6% NaCl concentration. The nutrients such as fructose (carbon source), beef extract (nitrogen source) and CaCl2 significantly influenced enzyme production. Central composite design and response surface methodology improved 3.2-fold enzyme yield than unoptimized culture medium. Fibrinolytic protease was purified by ammonium sulphate precipitation, dialysis and gel filtration chromatography. DISCUSSION: The molecular weight of an enzyme was found to be 23 kDa. It was active at a broad temperature (40-60 °C) and pH (7.0-9.0) ranges. Enzyme activity was enhanced by Ca2+ and Co2+ ions. The purified protease retained 100% enzyme activity in the presence of ethanol and acetone. Acetonitrile, butanol, DMSO, methanol and chloroform showed enzyme activity of 63%, 92.5%, 94.7%, 92.3% and 90.4%, respectively. The purified enzyme degraded 100% of human blood clot. CONCLUSION: The Bacillus flexus BF12 fibrinolytic enzyme shows promising potentials in nutraceutical and food fortification applications. The application of fibrinolytic enzymes could prevent CVDs.


Subject(s)
Bacillus/metabolism , Fibrinolytic Agents/chemistry , Serine Proteinase Inhibitors/biosynthesis , Culture Media , Humans , Hydrogen-Ion Concentration , India , Molecular Weight , Serine Proteinase Inhibitors/chemistry
2.
Molecules ; 24(14)2019 Jul 23.
Article in English | MEDLINE | ID: mdl-31340554

ABSTRACT

Scorpions, a characteristic group of arthropods, are among the earliest diverging arachnids, dating back almost 440 million years. One of the many interesting aspects of scorpions is that they have venom arsenals for capturing prey and defending against predators, which may play a critical role in their evolutionary success. Unfortunately, however, scorpion envenomation represents a serious health problem in several countries, including Iran. Iran is acknowledged as an area with a high richness of scorpion species and families. The diversity of the scorpion fauna in Iran is the subject of this review, in which we report a total of 78 species and subspecies in 19 genera and four families. We also list some of the toxins or genes studied from five species, including Androctonus crassicauda, Hottentotta zagrosensis, Mesobuthus phillipsi, Odontobuthus doriae, and Hemiscorpius lepturus, in the Buthidae and Hemiscorpiidae families. Lastly, we review the diverse functions of typical toxins from the Iranian scorpion species, including their medical applications.


Subject(s)
Antimicrobial Cationic Peptides/chemistry , Antineoplastic Agents/chemistry , Arthropod Proteins/chemistry , Scorpion Venoms/chemistry , Scorpions/chemistry , Animals , Antimicrobial Cationic Peptides/biosynthesis , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/therapeutic use , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Arthropod Proteins/biosynthesis , Arthropod Proteins/genetics , Arthropod Proteins/therapeutic use , Drug Discovery/methods , Gene Expression , Humans , Ion Channels/agonists , Ion Channels/antagonists & inhibitors , Ion Channels/metabolism , Iran , Metalloproteases/biosynthesis , Metalloproteases/isolation & purification , Metalloproteases/toxicity , Phospholipases A2/biosynthesis , Phospholipases A2/isolation & purification , Phospholipases A2/toxicity , Phylogeny , Scorpion Stings/physiopathology , Scorpion Venoms/biosynthesis , Scorpion Venoms/isolation & purification , Scorpions/classification , Scorpions/pathogenicity , Scorpions/physiology , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/isolation & purification , Serine Proteinase Inhibitors/toxicity , Species Specificity
3.
ACS Chem Biol ; 12(6): 1538-1546, 2017 06 16.
Article in English | MEDLINE | ID: mdl-28406289

ABSTRACT

Natural products and their semisynthetic derivatives are an important source of drugs for the pharmaceutical industry. Bacteria are prolific producers of natural products and encode a vast diversity of natural product biosynthetic gene clusters. However, much of this diversity is inaccessible to natural product discovery. Here, we use a combination of phylogenomic analysis of the microviridin biosynthetic pathway and chemo-enzymatic synthesis of bioinformatically predicted microviridins to yield new protease inhibitors. Phylogenomic analysis demonstrated that microviridin biosynthetic gene clusters occur across the bacterial domain and encode three distinct subtypes of precursor peptides. Our analysis shed light on the evolution of microviridin biosynthesis and enabled prioritization of their chemo-enzymatic production. Targeted one-pot synthesis of four microviridins encoded by the cyanobacterium Cyanothece sp. PCC 7822 identified a set of novel and potent serine protease inhibitors, the most active of which had an IC50 value of 21.5 nM. This study advances the genome mining techniques available for natural product discovery and obviates the need to culture bacteria.


Subject(s)
Biosynthetic Pathways/genetics , Depsipeptides/biosynthesis , Genome, Bacterial , Phylogeny , Serine Proteinase Inhibitors/biosynthesis , Bacterial Proteins/genetics , Computational Biology , Cyanobacteria/enzymology , Cyanobacteria/genetics , Data Mining , Genomics , Multigene Family
4.
Protein Expr Purif ; 126: 127-136, 2016 10.
Article in English | MEDLINE | ID: mdl-27353494

ABSTRACT

Cenchritis muricatus protease inhibitor II (CmPI-II) is a tight-binding serine protease inhibitor of the Kazal family with an atypical broad specificity, being active against several proteases such as bovine pancreatic trypsin, human neutrophil elastase and subtilisin A. CmPI-II 3D structures are necessary for understanding the molecular basis of its activity. In the present work, we describe an efficient and straightforward recombinant expression strategy, as well as a cost-effective procedure for isotope labeling for NMR structure determination purposes. The vector pCM101 containing the CmPI-II gene, under the control of Pichia pastoris AOX1 promoter was constructed. Methylotrophic Pichia pastoris strain KM71H was then transformed with the plasmid and the recombinant protein (rCmPI-II) was expressed in benchtop fermenter in unlabeled or (15)N-labeled forms using ammonium chloride ((15)N, 99%) as the sole nitrogen source. Protein purification was accomplished by sequential cation exchange chromatography in STREAMLINE DirectHST, anion exchange chromatography on Hitrap Q-Sepharose FF and gel filtration on Superdex 75 10/30, yielding high quantities of pure rCmPI-II and (15)N rCmPI-II. Recombinant proteins displayed similar functional features as compared to the natural inhibitor and NMR spectra indicated folded and homogeneously labeled samples, suitable for further studies of structure and protease-inhibitor interactions.


Subject(s)
Gastropoda/genetics , Pichia/metabolism , Serine Proteinase Inhibitors , Animals , Cattle , Gastropoda/metabolism , Humans , Nuclear Magnetic Resonance, Biomolecular , Pichia/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/genetics , Serine Proteinase Inhibitors/isolation & purification
5.
Angew Chem Int Ed Engl ; 55(32): 9398-401, 2016 08 01.
Article in English | MEDLINE | ID: mdl-27336908

ABSTRACT

Microviridins are a family of ribosomally synthesized and post-translationally modified peptides with a highly unusual architecture featuring non-canonical lactone as well as lactam rings. Individual variants specifically inhibit different types of serine proteases. Here we have established an efficient in vitro reconstitution approach based on two ATP-grasp ligases that were constitutively activated using covalently attached leader peptides and a GNAT-type N-acetyltransferase. The method facilitates the efficient in vitro one-pot transformation of microviridin core peptides to mature microviridins. The engineering potential of the chemo-enzymatic technology was demonstrated for two synthetic peptide libraries that were used to screen and optimize microviridin variants targeting the serine proteases trypsin and subtilisin. Successive analysis of intermediates revealed distinct structure-activity relationships for respective target proteases.


Subject(s)
Peptide Library , Peptides, Cyclic/pharmacology , Serine Proteinase Inhibitors/pharmacology , Subtilisin/antagonists & inhibitors , Trypsin/metabolism , Biosynthetic Pathways , Peptides, Cyclic/biosynthesis , Peptides, Cyclic/chemistry , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/chemistry , Subtilisin/metabolism
6.
Biochem Biophys Res Commun ; 452(3): 361-8, 2014 Sep 26.
Article in English | MEDLINE | ID: mdl-25159848

ABSTRACT

Protease inhibitors have been known to confer multiple stress tolerance in transgenic plants. We have assessed growth of yeast (Pichia pastoris GS115) strains expressing inhibitory repeat domains (PpIRD(+)) of previously characterized Capsicum annuum protease inhibitors under high salt, heavy metal and oxidative stress. PpIRD(+) strains exhibited multiple stress tolerance and showed differential molecular responses at transcriptional and translational level on exposure to stress inducing agents like heavy metal, high salt and H2O2. PpIRD(+) strains display significant reduction in metacaspase (Yca1) activity, the key enzyme in apoptosis, indicates the possibility of cross reactivity of IRDs (serine protease inhibitor) with cysteine proteases. PpIRD(+) and Saccharomyces cerevisiae knockout with Yca1 (ΔYca1) strain showed similar growth characteristics under stress, which indicated the delayed senescence due to cellular metacaspase inhibition. Molecular docking study showed a close proximity of IRDs reactive site and the active site of metacaspase in the complex that signified their strong interactions. Maintenance of GAPDH activity, primary target of metacaspase, in PpIRD(+) strain evidenced the inhibition of metacaspase activity and survival of these cells under stress. This report demonstrates a potential molecular mechanism of protease inhibitor-based multiple stress tolerance in yeast strains.


Subject(s)
Caspases/chemistry , Gene Expression Regulation, Fungal , Pichia/genetics , Saccharomyces cerevisiae/genetics , Serine Proteinase Inhibitors/genetics , Adaptation, Physiological , Capsicum/chemistry , Capsicum/metabolism , Caspases/deficiency , Caspases/genetics , Caspases/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/genetics , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/metabolism , Hydrogen Peroxide/pharmacology , Metals, Heavy/toxicity , Microbial Viability , Molecular Docking Simulation , Pichia/drug effects , Pichia/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Salinity , Serine Proteinase Inhibitors/biosynthesis , Signal Transduction , Sodium Chloride/pharmacology , Stress, Physiological
7.
J Recept Signal Transduct Res ; 34(3): 154-61, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24308378

ABSTRACT

Directed evolution is a very popular strategy for improving biophysical properties and even for generating proteins with novel functions. Recent advances in combinatorial protein engineering mean it is now possible to develop protein scaffolds that could substitute for whole antibody-associated properties as emerging therapeutic proteins. In particular, disulfide-rich proteins are attractive templates for directed evolution in the search for novel molecules because they can regulate the activities of receptors, enzymes, and other molecules. Previously, we demonstrated that functional regulatory molecules against interleukin-6 receptor (IL-6R) could be obtained by directed evolution of the three-finger toxin (3F) scaffold. In the present study, trypsin was selected as a target for directed evolution to further explore the potential use of the 3F cDNA display library. After seven rounds of selection, the DNA sequences converged. The recombinant proteins produced by the selected candidates had inhibitory activity against trypsin (Ki of 33-450 nM). Three of the six groups had Ki values that were comparable to bovine pancreatic trypsin inhibitor and soybean trypsin inhibitor. Two of the candidates also had inhibitory effects against chymotrypsin and kallikrein. This study suggests that 3F protein is suitable for the preparation of high-diversity libraries that can be utilized to obtain protease inhibitors. In addition to our previous successful targeting of IL-6R, the technique developed in our studies may have wide applications in the generation of regulatory molecules for targets of interest, such as receptors, enzymes for research, diagnostic applications, and therapeutic uses.


Subject(s)
Directed Molecular Evolution/methods , Peptide Hydrolases/chemistry , Peptides/chemistry , Peptides/metabolism , Recombinant Proteins/biosynthesis , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/chemistry , Gene Library , Peptides/genetics , Recombinant Proteins/genetics , Serine Proteinase Inhibitors/genetics
8.
Planta ; 237(5): 1287-96, 2013 May.
Article in English | MEDLINE | ID: mdl-23371287

ABSTRACT

Plant protease inhibitors (PIs) are among the most well-studied and widely distributed resistance traits that plants use against their herbivore attackers. There are different types of plant PIs which putatively function against the different types of proteases expressed in insect guts. Serine protease inhibitors (SPIs) and cysteine protease inhibitors (CPIs) are hypothesized to differentially function against the predominant gut proteases in lepidopteran and coleopteran herbivores, respectively. Here, we test the hypothesis that tall goldenrod, Solidago altissima, can specifically respond to damage by different herbivores and differentially induce SPIs and CPIs in response to damage by lepidopteran and coleopteran herbivores. Moreover, we ask if the concerted induction of different types of PIs accounts for variation in induced resistance to herbivory. We altered and optimized a rapid and effective existing methodology to quantitatively analyze both SPI and CPI activity simultaneously from a single tissue sample and to use the same plant extracts directly for characterization of inhibitory effects on insect gut protease activity. We found that both SPIs and CPIs are induced in S. altissima in response to damage, regardless of the damaging herbivore species. However, only SPIs were effective against Spodoptera exigua gut proteases. Our data suggest that plant PI responses are not necessarily specific to the identity of the attacking organism but that different components of generally induced defense traits can specifically affect different herbivore species. While providing an efficient and broadly applicable methodology to analyze multiple PIs extracted from the same tissue, this study furthers our understanding of specificity in induced plant resistance.


Subject(s)
Asteraceae/metabolism , Asteraceae/parasitology , Cysteine Proteinase Inhibitors/biosynthesis , Cysteine Proteinase Inhibitors/metabolism , Herbivory , Insecta/pathogenicity , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/metabolism , Animals
9.
Sheng Wu Gong Cheng Xue Bao ; 29(11): 1607-16, 2013 Nov.
Article in Chinese | MEDLINE | ID: mdl-24701826

ABSTRACT

Hespintor is an unknown function protein that was got from hepatoblastoma cell lines HepG2 by suppression subtractive hybridization technique (SSH), sequence analysis showed that the protein is a new member of secretory type of Kazal type serine protease inhibitor (Serpin) family, and has high homology with esophageal cancer related gene 2 (ECRG2). The coding sequence of Hespintor's Kazal domain was subcloned into prokaryotic expression vector pET-40b(+), then transformed into Rosetta (DE3). A recombinant protein about 42 kDa in the form of inclusion body was optimization expressed by inducing with 0.25 mmol/L IPTG, 30 degrees C for 5 h. and its specificity was confirmed via Western blotting. The recombinant protein was purified by metal chelate affinity chromatography (MCAC) and anion-exchange chromatography. The preliminary experimental result showed that the recombinant protein can inhibit trysin hydrolysis activity specifically. The result clearly demonstrated that Hespintor, as a novel member of Serpin, would be valuable in developing anti-tumor agents.


Subject(s)
Genetic Vectors/genetics , Proteinase Inhibitory Proteins, Secretory , Recombinant Proteins/biosynthesis , Serine Proteinase Inhibitors/biosynthesis , Escherichia coli/genetics , Escherichia coli/metabolism , Hep G2 Cells , Humans , Recombinant Proteins/genetics , Serine Peptidase Inhibitors, Kazal Type , Serine Proteinase Inhibitors/classification , Serine Proteinase Inhibitors/genetics
10.
Cancer Gene Ther ; 19(12): 875-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23079671

ABSTRACT

Hepatocarcinoma represents one of the most malignant cancer types. Esophageal cancer-related gene 2 (ECRG2) is found to be critical in the process of carcinogenesis. It regulates urokinase-type plasmin activator receptor and extracellular matrix function and its polymorphism in exon 4 is associated with cancer relapse. To explore new strategies to fight against cancer, here we first systematically evaluated the therapeutic potential as a biological tool using adenoviral vector (Ad-ECRG2). Ad-ECRG2 is exogenously expressed in cytoplasm and is potent to suppress the growth of cancer cell by inducing apoptosis as effective as Ad-p53. Ad-ECRG2 is able to suppress the invasion and adhesion of cancer cells at low titers. It alters the expression of a panel of cancer-related molecules, including nuclear factor-kB, matrix metalloproteinase 2 and E-cadherin, contributing to reverse malignancy phenotype of cancer cells. In vivo experiments show a significant inhibition of cancer growth by intratumoral Ad-ECRG2 administration. No evident toxicity was observed in the model animal during the study. We concluded that ECRG2 is a potential molecular target in biological therapy strategies for cancer treatment.


Subject(s)
Adenoviridae/genetics , Carcinoma, Hepatocellular/therapy , Liver Neoplasms/therapy , Proteinase Inhibitory Proteins, Secretory/genetics , Serine Proteinase Inhibitors/genetics , Adenoviridae/metabolism , Animals , Apoptosis/genetics , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Adhesion/genetics , Cell Line, Tumor , Genetic Vectors/genetics , Hep G2 Cells , Humans , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , MCF-7 Cells , Mice , Proteinase Inhibitory Proteins, Secretory/biosynthesis , Serine Peptidase Inhibitors, Kazal Type , Serine Proteinase Inhibitors/biosynthesis , Transfection/methods , Xenograft Model Antitumor Assays
11.
Curr Mol Med ; 12(8): 1050-67, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22827436

ABSTRACT

PC4 or PCSK4 belongs to the 9-member superfamily of mammalian subtilases collectively called Proprotein Convertases or Proprotein Convertase Subtilisin/Kexins that convert inactive precursor proteins into their active mature forms by endoproteolytic cleavage. PC4-activity plays a crucial role in mammalian fertilization via activation of sperm surface proteins. PC4 knockout mice exhibit severely impaired male fertility due to premature sperm acrosome reaction. Regulation of sperm-PC4 activity during its storage and transport through epididymis is an important determinant for ultimate egg-binding and fertilizing capacities of sperms. Herein we show that epididymal serpin CRES (cystatin related epididymal spermatogenic) recombinant protein inhibits PC4 activity in vitro in a differential manner when measured against the fluorogenic substrate Boc- RVRR-MCA depending on its oligomeric state. Thus while CRES-dimer exhibits K(i) ∼8 µM, the corresponding monomer showed K(i) > 100 µM. Both forms also blocked PC4-mediated processing of human proIGF-2 in human placenta tropoblast cell line with dimer being more efficient. Using specific inhibitors and substrates, we also demonstrated the presence of PC4-like activity and CRES protein in varying levels in the fluids of various epididymal compartments. Our observations suggest a potential function of CRES as a regulator of PC4 in sperm-egg interaction and fertilization.


Subject(s)
Cystatins/chemistry , Epididymis/enzymology , Serine Endopeptidases/chemistry , Serine Proteinase Inhibitors/chemistry , Amino Acid Sequence , Animals , Binding, Competitive , Cell Line , Chromatography, High Pressure Liquid , Cystatins/biosynthesis , Cystatins/isolation & purification , Humans , Male , Mice , Molecular Sequence Data , Proprotein Convertases , Protein Binding , Protein Multimerization , Protein Structure, Quaternary , Proteolysis , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Serine Endopeptidases/biosynthesis , Serine Endopeptidases/isolation & purification , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Subtilisins
12.
J Biosci Bioeng ; 112(2): 114-7, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21543256

ABSTRACT

AFUEI, an elastase inhibitor produced by Aspergillus fumigatus strongly inhibits the elastolytic activity of A. fumigatus etc. To purify AFUEI, we constructed a strain that overproduces AFUEI by introducing the gene encoding AFUEI (Genbank accession no. AB546725) under control of the amyB promoter into the heterologous host Aspergillus oryzae. A. oryzae TF-4 displayed strong elastase inhibitory activity and produced considerably more AFUEI than that of A. fumigatus. Furthermore, AFUEI could be purified using culture broth and single ultrafiltration (UF) treatment, allowing for the effective production of AFUEI for use in clinical trials.


Subject(s)
Antifungal Agents/metabolism , Aspergillus fumigatus/enzymology , Aspergillus oryzae/genetics , Fungal Proteins/biosynthesis , Pancreatic Elastase/antagonists & inhibitors , Serine Proteinase Inhibitors/biosynthesis , Antifungal Agents/pharmacology , Cells, Cultured , Fungal Proteins/genetics , Fungal Proteins/pharmacology , Humans , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/pharmacology , Serine Proteinase Inhibitors/genetics , Serine Proteinase Inhibitors/pharmacology
13.
Arch. Soc. Esp. Oftalmol ; 86(3): 77-80, mar. 2011. tab, graf
Article in Spanish | IBECS | ID: ibc-92481

ABSTRACT

Objetivo: El factor derivado del epitelio pigmentario (PEDF) es un factor antiangiogénico yneurotrófico que recientemente también ha demostrado tener poder antioxidante y antiinflamatorio.El objetivo de nuestro estudio fue determinar los niveles de PEDF en humoracuoso de ojos con uveítis anterior aguda idiopática (UAAI).Métodos: Se realizó un estudio comparativo con grupo control. El humor acuoso fue estudiadoen 20 ojos de 20 pacientes con UAAI. El grupo control comprendía 20 muestras de humoracuoso de 20 pacientes intervenidos de cataratas, sin ninguna otra enfermedad ocular nisistémica. Los niveles de PEDF se determinaron mediante el test de ELISA.Resultados: La concentración de PEDF en humor acuoso fue marcadamente superior en lospacientes con UAAI que en los sujetos control (test U Mann-Whitney, p < 0,001). Los nivelesde PEDF fueron 6.291.637,70±8.564.836,48 pg/ml (media±DS) en los ojos con UAAI y449.178,10±158.670,19 pg/ml en los ojos del grupo control.Conclusiones: Los niveles de PEDF en humor acuoso están aumentados en ojos con UAAI locual podría considerarse como un mecanismo de autoprotección frente a la inflamación(AU)


Objective: Pigment epithelium-derived factor (PEDF) is an antiangiogenic/neurotrophic dualfunctional factor, and recently it was also shown to mediate antioxidative and antiinflammatoryaction. The purpose of this study was to evaluate the levels of PEDF in theaqueous humor in eyes with idiopathic acute anterior uveitis (IAAU).Methods: A comparative control study. Aqueous humor was collected from 20 eyes of 20 patients with IAAU. The control group included 20 aqueous humor samples from 20 patients who underwent a cataract surgery and without any other ocular or systemic diseases. Levels of PEDF were determined with the ELISA test. Results: Concentration of PEDF in aqueous humor was remarkably higher in patientswith IAAU than in control subjects (Mann-Whitney U test, P < .001). Levels of PEDF were6,291,637.70±8,564,836.48 pg/ml (mean±SD) in eyes with IAAU and 449,178.10±158,670.19pg/ml in the eyes of the control group.Conclusion: The aqueous humor PEDF levels are increased in eyes with IAAU and may beincreased as self-protection against inflammation(AU)


Subject(s)
Humans , Male , Female , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/pharmacology , Retinal Pigment Epithelium , Aqueous Humor/chemistry , Uveitis, Anterior/metabolism , Angiogenesis Inhibitors , Inflammation Mediators , Anti-Inflammatory Agents , Antioxidants
14.
Anticancer Res ; 30(7): 2739-44, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20683007

ABSTRACT

UNLABELLED: Ovarian cancer (OC) is a disease with poor prognosis, and molecular markers are needed to improve understanding of disease progression and resultant treatment. Only limited data concerning the expression of maspin, a serine protease inhibitor, in ovarian cancer (OC) are available. This study investigates the prognostic value of maspin expression (ME) in various OC cell lines and clinical tissue specimens from OC patients. PATIENTS AND METHODS: Tumour purified mouse anti-human maspin monoclonal antibody was applied to tissue specimens from 87 OC patients. ME was recorded by an immunoreactive score, which was correlated with grading, stage, histopathological subtypes and overall survival. Additionally ME was evaluated in established ovarian cancer cell lines (HEY, SKOV3, OVCAR3/8) and paclitaxel- and docetaxel-resistant HEY cells by QRT-PCR. RESULTS: There was significant correlation between cytoplasmatic ME and overall survival (p<0.05). OC patients with high levels of ME had a median survival of 28 vs. 57 months for those with low levels. Significant differential ME was detected between benign, borderline ovarian lesions and OC, as well as among different tumour gradings. Normal ovarian epithelial cells expressed less maspin than ovarian cancer cells as measured by QRT-PCR. Docetaxel- and paclitaxel-resistant ovarian cell lines showed an even higher level of ME, suggesting an unfavourable role of ME in OC cell lines. CONCLUSION: Maspin is expressed differentially in OC, and low expression levels of maspin are correlated with a longer survival.


Subject(s)
Adenocarcinoma/metabolism , Ovarian Neoplasms/metabolism , Serine Proteases/metabolism , Serine Proteinase Inhibitors/biosynthesis , Serpins/biosynthesis , Adenocarcinoma/enzymology , Adenocarcinoma/pathology , Cell Line, Tumor , Cell Nucleus/metabolism , Cytoplasm/metabolism , Female , Humans , Immunohistochemistry , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/enzymology , Ovarian Neoplasms/pathology , Serine Proteinase Inhibitors/metabolism , Serpins/metabolism
15.
Dev Comp Immunol ; 34(10): 1101-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20540960

ABSTRACT

A five-domain Kazal-type serine proteinase inhibitor, SPIPm2, from Penaeus monodon has recently been implicated in antiviral responses for it is up-regulated upon viral infection and needs further studies. The SPIPm2 genomic gene was composed of seven exons and six introns. The genomic DNA segments coding for each Kazal domain were separated by introns of variable lengths supporting the hypothesis of gene duplication in the Kazal-type gene family. RT-PCR and Western blot analysis revealed that the SPIPm2 transcript and its five-domain protein product were expressed mainly in the hemocytes and less in gill, heart and antennal gland. Upon white spot syndrome virus (WSSV) infection, the SPIPm2 was only detected in the hemocytes and plasma. Immunocytochemical study of P. monodon hemocytes showed that the percentage of SPIPm2-producing hemocytes was reduced by about half after WSSV infection. Quantitative RT-PCR revealed further that the SPIPm2 was up-regulated early in the hemocytes of WSSV-infected shrimp and gradually reduced as the infection progressed. Injection of the recombinant SPIPm2 (rSPIPm2) prior to WSSV injection resulted in a significant inhibition of WSSV replication. The rSPIPm2 injection also prolonged the mortality rate of WSSV-infected shrimp. Therefore, the SPIPm2 was involved in the innate immunity against WSSV infection in shrimp.


Subject(s)
DNA Virus Infections/immunology , Hemocytes/metabolism , Penaeidae , Recombinant Proteins/biosynthesis , Serine Proteinase Inhibitors/biosynthesis , White spot syndrome virus 1/physiology , Animals , DNA Virus Infections/genetics , DNA Virus Infections/metabolism , Exons/genetics , Gene Expression Profiling , Hemocytes/immunology , Hemocytes/pathology , Hemocytes/virology , Immunity, Innate/drug effects , Immunohistochemistry , Introns/genetics , Protein Structure, Tertiary/genetics , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Serine Proteinase Inhibitors/administration & dosage , Serine Proteinase Inhibitors/genetics , Virus Replication/drug effects , White spot syndrome virus 1/pathogenicity
16.
Mol Microbiol ; 73(5): 924-37, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19691450

ABSTRACT

Nodularia spumigena is a filamentous nitrogen-fixing cyanobacterium that forms toxic blooms in brackish water bodies worldwide. Spumigins are serine protease inhibitors reported from a single strain of N. spumigena isolated from the Baltic Sea. These linear tetrapeptides contain non-proteinogenic amino acids including a C-terminal alcohol derivative of arginine. However, very little is known about these compounds despite the ecological importance of N. spumigena. We show that spumigins are assembled by two non-ribosomal peptide synthetases encoded in a 21 kb biosynthetic gene cluster. The compact non-ribosomal peptide synthetase features a reductive loading and release mechanism. Our analyses demonstrate that the bulk of spumigins produced by N. spumigena are released as peptide aldehydes in contrast to earlier findings. The main spumigin E variant contains an argininal residue and is a potent trypsin inhibitor. Spumigins were present in all of the N. spumigena strains isolated from the Baltic Sea and comprised up to 1% of the dry weight of the cyanobacterium. Our results demonstrate that bloom-forming N. spumigena strains produce a cocktail of enzyme inhibitors, which may explain in part the ecological success of this cyanobacterium in brackish water bodies worldwide.


Subject(s)
Bacterial Proteins/biosynthesis , Nodularia/metabolism , Oligopeptides/biosynthesis , Serine Proteinase Inhibitors/biosynthesis , Bacterial Proteins/chemistry , Chromatography, Liquid , Gene Order , Genes, Bacterial , Mass Spectrometry , Molecular Structure , Multigene Family , Nodularia/isolation & purification , Oligopeptides/chemistry , Peptide Biosynthesis, Nucleic Acid-Independent , Peptide Synthases/metabolism , Phylogeny , Seawater/microbiology , Sequence Homology, Amino Acid
17.
Fish Shellfish Immunol ; 26(6): 885-97, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19379816

ABSTRACT

Serine proteinase inhibitor plays an essential role in arthropods by restraining the activities of endogenic or exogenic serine proteinases. Four Kazal-type serine proteinase inhibitors, Fcspi-1-4, from the hepatopancreas of Chinese white shrimp, Fenneropenaeus chinensis, were cloned and identified. The open reading frames (ORFs) of Fcspis are 1389, 1236, 1080, and 939 base pairs, encode the pre-proteins of 462, 411, 359, and 312 amino acids and form the 9, 8, 7, and 6 typical Kazal domains, respectively. When analyzing the amino acid sequences of the four inhibitors, it was found that they might have been derived from the same transcript, which was subjected to alternative splicing, and none of the Kazal domains were identical within each inhibitor. Multiple alignments showed that the Kazal inhibitors were homologous with a conserved motif of Cx(3)Cx(6)VCGSDGxTYx(3)CxLx(5)Cx(5)ITx(6)GC. The results from RT-PCR indicated that the expression of Fcspis as a whole was upregulated by bacterial challenge, no obvious change was noticed after viral challenge, and Fcspi-1 had a similar expression pattern with that of Fcspis. Recombinant FcSPIs were successfully expressed in bacteria and purified for further study. Recombinant FcSPI-1 was sensitive to DTT and had thermal stability. The inhibitory kinetics assay suggested that rFcSPI-1 was a mixed-type fast tight binding inhibitor with inhibitory activities against subtilisin A at a molar ratio of 1:1, 1:2 against proteinase K, and 2:1 against elastase. It can firmly bound to two Gram-positive and one Gram-negative bacteria but without anti-bacterial ability. In addition, it inhibited the activities of both bacterial-secreted proteinases and natural chymotrypsin of Chinese white shrimp, suggesting that FcSPI-1 may participate in the immune defence response by inhibition of bacterial pathogen proteinases and possibly be involved in the regulation of shrimp proteinase activity.


Subject(s)
Hepatopancreas/metabolism , Penaeidae/metabolism , Serine Endopeptidases/metabolism , Serine Proteinase Inhibitors/biosynthesis , Amino Acid Motifs , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Gram-Negative Bacteria/enzymology , Gram-Positive Bacteria/enzymology , Immunoblotting/veterinary , Kinetics , Molecular Sequence Data , Penaeidae/immunology , RNA/chemistry , RNA/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sequence Alignment , Serine Proteinase Inhibitors/genetics , Serine Proteinase Inhibitors/isolation & purification , Serine Proteinase Inhibitors/pharmacology
18.
Proteomics ; 9(8): 2202-16, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19322782

ABSTRACT

The liver has the ability to restore its functional capacity following injury or resection and the priming of liver regeneration is a complex process that has not been completely elucidated. In the current research, to further reveal the priming mechanism of liver regeneration, hepatocyte total protein and hepatocyte cytosol of the rats at 4 h after 2/3 partial hepatectomy (PHx) were studied, respectively, by 2-DE and 2-D blue native gel electrophoresis. Seventeen unique differential proteins were identified in hepatocyte total protein samples. Nine differential protein complexes containing 41 protein components were identified in hepatocyte cytosol samples. For the first time, at the priming stage of liver regeneration, the variations of serine protease inhibitor 2c, sulfite oxidase and valosin-containing protein (VCP) were presented and validated by Western blotting, and the VCP complex was further validated by antibody super-shift experiments. The current results suggested that at 4 h after PHx, VCP complex was down-regulated in hepatocyte cytosol, apoptosis pathways were inhibited, nuclear factor-kappaB and interleukin 6 pathways worked together and triggered the liver regeneration.


Subject(s)
Liver Regeneration/physiology , Multiprotein Complexes/biosynthesis , Adenosine Triphosphatases/biosynthesis , Animals , Apoptosis , Cell Cycle Proteins/biosynthesis , Electrophoresis, Gel, Two-Dimensional , Hepatectomy , Hepatocytes/chemistry , Hepatocytes/metabolism , Liver/cytology , Liver/physiology , Liver/surgery , Male , Metabolic Networks and Pathways , Rats , Serine Proteinase Inhibitors/biosynthesis , Signal Transduction , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Sulfite Oxidase/biosynthesis , Valosin Containing Protein
19.
Protein Expr Purif ; 61(2): 117-21, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18634882

ABSTRACT

The synthetic gene (sPI-II) harboring the chymotrypsin (C1) and trypsin (T1) inhibitor domains of the Nicotiana alata serine proteinase inhibitor II gene has been previously expressed, and extracellular protease activity was shown to be reduced in the suspension culture medium. In this study, the sPI-II gene was introduced into transgenic rice cells expressing rhGM-CSF (recombinant human granulocyte-macrophage colony-stimulating factor), in an effort to reduce protease activity and increase rhGM-CSF accumulation in the suspension culture medium. The integration and expression of the introduced sPI-II gene in the transgenic rice cells were verified via genomic DNA PCR amplification and Northern blot analysis, respectively. Relative protease activity was found to have been reduced and rhGM-CSF production was increased 2-fold in the co-transformed cell suspension culture with rhGM-CSF and the sPI-II gene, as compared with that observed in the transformed cell suspension culture expressing rhGM-CSF only. These results indicate that a transformed plant cell suspension culture system expressing the proteinase inhibitor can be a useful tool for increasing recombinant protein production.


Subject(s)
Gene Expression , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Oryza/genetics , Plants, Genetically Modified/genetics , Serine Proteinase Inhibitors/genetics , Blotting, Northern , Cell Culture Techniques , Culture Media, Conditioned/chemistry , Culture Media, Conditioned/metabolism , Enzyme Activation/genetics , Genetic Vectors/genetics , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Granulocyte-Macrophage Colony-Stimulating Factor/isolation & purification , Humans , Oryza/cytology , Oryza/metabolism , Plants, Genetically Modified/cytology , Plants, Genetically Modified/metabolism , Polymerase Chain Reaction/methods , Recombinant Proteins , Serine Proteinase Inhibitors/biosynthesis , Time Factors , Nicotiana/genetics , Transformation, Genetic/genetics
20.
Sheng Wu Gong Cheng Xue Bao ; 24(3): 500-3, 2008 Mar.
Article in Chinese | MEDLINE | ID: mdl-18589830

ABSTRACT

SKPI (shrimp Kunitz-type protease inhibitor) from Marsupenaeus japonicus is a member of serine protease inhibitors which play an important role in the arthropod immunity. To fully understand its function in the innate immunity of shrimp, the skpi gene was cloned into a modified pPIC9K vector with a 6-His tag and expressed by Pichia pastoris GS115. The secretory SKPI was purified from the medium with high purity by using Ni Sepharose High Performance. This results also indicated that the purified SKPI could inhibit the activity of trypsin specifically.


Subject(s)
Aprotinin/biosynthesis , Pandalidae/chemistry , Pichia/metabolism , Recombinant Proteins/biosynthesis , Serine Proteinase Inhibitors/biosynthesis , Trypsin Inhibitors , Animals , Aprotinin/genetics , Aprotinin/isolation & purification , Pichia/genetics , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Serine Proteinase Inhibitors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...